The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+5.2% to $37.20
Predicted High$37.20at 6 months
Predicted Low$35.45in 2 weeks
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 12, 2026 12:54 am
Bull
RELX trends higher to
$37.20
(+5.2% from $35.37)
by Feb 2027.
flat-then-break
ThesisRELX is a high-quality compounder trading near composite fair value with strong momentum but stretched vs value lens. Low beta and no near-term catalyst suggest a drifting path modestly upward toward the anchored-PE and DCF zone, with occasional consolidation given the risk-on tape favoring higher-beta names.
Invalidated ifA break below $32 on volume or a regime shift to risk-off with RELX failing to outperform would invalidate the mild uptrend thesis.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $35.37 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 12, 2026
—
$35.37at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 26, 2026
$32.78–$37.96typical range · internal point $35.45
—
±7.3%
7/10
Low-vol drift, no catalyst, risk-on tape neutral
What actually happened:
closed $35.88
on Aug 25, 2026 = +1.4% vs the call
(predicted +0.2%)
· direction HIT
(called flat, was flat)
· off by 1.2 pp
· accuracy 10/10
· typical range ±7.3%:
inside the band
· S&P -0.9%
over the same window — beat it
1 month
Sep 12, 2026
$31.62–$39.12typical range · internal point $35.60
—
±10.6%
6/10
Quiet compounder holds near fair value
2 months
Oct 12, 2026
$35.90
—
+1.5%
5/10
Q3 earnings anticipation builds mild bid
3 months
Nov 12, 2026
$36.40
—
+2.9%
5/10
Earnings beat streak likely extends, modest lift
4 months
Dec 12, 2026
$36.70
—
+3.8%
4/10
Year-end quality rotation supports defensives
5 months
Jan 12, 2027
$36.90
—
+4.3%
4/10
January drift toward DCF anchor zone
6 months
Feb 12, 2027
$37.20
—
+5.2%
4/10
Value gravity pulls toward anchored-PE midpoint
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$36.26
(+2.5%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.